Dongsung on phase III studies for a nasal spray type of insulin

Published: 2005-05-11 06:59:00

Updated: 2005-05-11 06:59:00

Dongsung agreed with Bentley pharmaceuticals of America for a joint phase III clinical study of the nasal spray type of insulin and a signing ceremony at the dynasty hall of Shilla hotel (2nd fl.) on May 10 (Tuesday) at 10:30 a.m.

President Lee Yang-goo of Dongsung visited Bentley earlier in A...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK